Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation of vaccinations and by vaccination status (children with documentation of vaccinations).

<p>Seroprevalence of measles-, mumps- and rubella lgG antibody titres in children by documentation of vaccinations and by vaccination status (children with documentation of vaccinations).</p

Seroprevalence of measles-, mumps- and rubella lgG antibody titres in German children by sociodemografic factors.

<p>Seroprevalence of measles-, mumps- and rubella lgG antibody titres in German children by sociodemografic factors.</p

Multivariate odds ratios (OR) for the association between sociodemographic factors and the risk of a negative measles-, mumps- and rubella antibody titres in German children and adolescents.

<p>Legend <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042867#pone-0042867-t003" target="_blank">Table 3</a>: All multivariate models were adjusted for the parental reported history of the respective (measles/mumps/rubella) infection.</p>*<p>explained variation [Nagelkerke]: 0.056; n = 13.091.</p>**<p>explained variation [Nagelkerke]: 0.019; n = 13.044.</p>***<p>explained variation [Nagelkerke]: 0.040; n = 13.082;</p

Prevalence of negative and equivocal Measles IgG antibody titres by age and gender.

<p>Prevalence of negative and equivocal Measles IgG antibody titres by age and gender.</p

Flow chart on study subjects.

<p>Flow chart on study subjects.</p

Multivariate odds ratios (OR) for the association between time since last vaccination and the risk of a negative measles-, mumps- and rubella antibody titres in German children and adolescents.

<p>Legend <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0042867#pone-0042867-t005" target="_blank">Table 5</a>.</p><p>All multivariate models were adjusted for age, gender and the parental reported history of the respective (measles/mumps/rubella) infection. In addition, the multivariate measles model was adjusted for age at first measles vaccination and migration background. In all models subjects who had received their first respective (measles/mumps/rubella) vaccination no more than 21 days before were excluded.</p>*<p>Explained variation [Nagelkerke]: 0.056; n = 11.018.</p>**<p>Explained variation [Nagelkerke]: 0.057; n = 11.049.</p>***<p>Explained variation [Nagelkerke]: 0.075; n = 10.816.</p

Seroprevalence of MMR IgG-Titres and MMR vaccination rate (at least one dose) by age.

<p>Distribution of antibodies to measles, mumps and rubella in German children aged 1–17 year; vaccination coverage of at least one dose of measles, mumps and rubella vaccine (mono-, bi- or three-valent vaccines) in those who provided their vaccination card.</p

Transfer of delictual liability in competition law

Transfer of delictual liability in competition law The issue of delictual liability for anti-competitive practices and subsequent identification of party which is to be penalized for them is, with regard to effective protection of competition, a crucial one. However, it is also a topic which is, with a few notable exceptions, often addressed only superficially. This work therefore aims to perform thorough analysis of rules applicable to transfer of delictual liability both on European and Czech national level. For this purpose, it is divided into two major and comparatively separate parts. First of them is devoted to a detailed analysis of the European court of justice case-law related to the possibility of transfer of liability from the original infringer to a different legal entity. The aim is not only to identify particular criteria, which may affect such transfer of liability, but also to illustrate the direction in which the case-law of the European court of justice evolved and in which it is probable to continue heading in the future. The second part of this work deals with regulation of the transfer of liability within the Czech legal framework, commencing with adoption of Act no. 63/1991 Coll., on the Protection of Competition, up to the present. Considering the decisive influence of the..

Additional file 3: of Gene expression profiling of rubella virus infected primary endothelial cells of fetal and adult origin

Ranking of commonly up- and down-regulated genes in the endothelial cells following RV infection. (PDF 52 kb